Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Link to relevant study record(s)

Reference
Endpoint:
basic toxicokinetics, other
Remarks:
Expert Statement
Type of information:
other: Expert Statement
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: Expert Statement, no study available
Objective of study:
absorption
distribution
excretion
metabolism
Principles of method if other than guideline:
Expert statement
GLP compliance:
no
Specific details on test material used for the study:
not applicable
Details on test animals or test system and environmental conditions:
not applicable
Duration and frequency of treatment / exposure:
not applicable
Positive control reference chemical:
not applicable
Details on study design:
not applicable
Details on dosing and sampling:
not applicable
Statistics:
not applicable
Details on absorption:
Generally, oral absorption is favoured for molecular weights below 500 g/mol. The good water solubility of 1737 mg/L enables the substance to readily dissolve in the gastrointestinal fluids. In combination with the low molecular weight of less than 200 g/mol the molecules can pass through aqueous pores or can also be carried through the epithelial barrier by the bulk passage of water. The moderate log Pow value (between -1 and 4) is also favourable for passive diffusion. Taken together, the physiochemical properties indicate that the substance becomes bioavailable following the oral route. This assumption is confirmed by the results of the oral toxicity study, where mortality occurred.
Due to the low volatility (vapour pressure <0.5 kPa) of the substance it is unlikely that the substance will be available as a vapour to a large extend, but if it is the case absorption via inhalation route might be possible due to the water solubility and the moderate log Pow value, enabling uptake directly across the respiratory tract epithelium by passive diffusion.
Dermal absorption may also take place, favoured by the water solubility and the log Pow value, and also by the size of the molecule, even though the test results did not indicate this: No mortality occurred in an acute dermal toxicity study and no indications of a skin sensitising potential were revealed. The dermal permeability constant Kp was calculated to be 0.00348 cm/hr (Dermwin v.2.02). The test substance was found to be irritant to skin, indicating that dermal uptake might be facilitated by damaging the skin.
Details on distribution in tissues:
The physicochemical properties of the substance favour systemic absorption following oral, inhalative and dermal uptake. The systemic absorption and distribution within the body is also demonstrated by the decreased viability index of PND 4 and decreased body weights on PND 13 of the F1 pups in the OECD 422 study.
Direct transport through aqueous pores is likely to be an entry route to the systemic circulation. After being absorbed into the body, the substance is most likely distributed into the interior part of cells due to its very slightly lipophilic properties (log Pow 1.79) and in turn the intracellular concentration may be slightly higher than extracellular concentration particularly in adipose tissues.
The log Pow of the test substance indicates no bioaccumulation potential as it is below 3 and the most likely uptake mechanism into cells is passive diffusion, therefore the test substance is not considered to be bioaccumulative.
Details on excretion:
The test substance will be excreted most likely in its metabolised form. The likely excretion pathway of the test substance and its metabolites is via urine as substances with a molecular weight below 300 g/mol are prone to this pathway.
Metabolites identified:
yes
Remarks:
predicted yb QSAR Toolbox v4.2
Details on metabolites:
The in vitro rat liver metabolic simulator of QSAR toolbox v4.2 predicted formaldehyde, 1-(4-Hydroxyphenyl)ethanone, 1-(4-Methoxyphenyl)ethanol and formic acid as metabolites. Formaldehyde and will be further oxidized into formate and eventually to carbon dioxide. 1-(4-Hydroxyphenyl)ethanone and 1-(4-Methoxyphenyl)ethanol may further undergo conjugation reactions to facilitate excretion via urine.
Conclusions:
Bioaccumulation of the test substanceis not considered critical based on expert statement.
Executive summary:

Based on physicochemical characteristics absorption by the oral and dermal route takes place. This assumption is supported by the results of the oral acute toxicity study, revealing mortality at <2000 mg/kg bw. Absorption via inhalation route is unlikely, but may also take place. Bioaccumulation of the substance is not expected.After being absorbed into the body,4’-methoxyacetophenone ismost likely distributed into the interior part of cells due to its very slightly lipophilic properties (log Pow 1.79) and in turn the intracellular concentration may be slightly higher than extracellular concentration particularly in adipose tissues. A metabolic activation to more toxic metabolites is not to be expected. Predicted metabolites formed in the liver and upon skin contact are presented above (QSAR tollbox v4.2). In general, phase I and II metabolism reactions will render the molecule more polar to faciliate excretion via urine.

 

Description of key information

Based on physicochemical characteristics absorption by the oral and dermal route takes place. This assumption is supported by the results of the oral acute toxicity study, revealing mortality at <2000 mg/kg bw. Absorption via inhalation route is unlikely, but may also take place. Bioaccumulation of the substance is not expected.After being absorbed into the body,4’-methoxyacetophenone ismost likely distributed into the interior part of cells due to its very slightly lipophilic properties (log Pow 1.79) and in turn the intracellular concentration may be slightly higher than extracellular concentration particularly in adipose tissues. A metabolic activation to more toxic metabolites is not to be expected. Predicted metabolites formed in the liver and upon skin contact are presented above (QSAR tollbox v4.2). In general, phase I and II metabolism reactions will render the molecule more polar to faciliate excretion via urine.

 

Key value for chemical safety assessment

Bioaccumulation potential:
no bioaccumulation potential

Additional information

4’-methoxyacetophenoneis a mono-constituent substance. It is a colourless to pale yellow waxy solid at room temperature with a molecular weight of150.18g/mol. The substance is soluble in water (1737 mg/L at 20 °C). The log Pow was determined to be 1.79 at 20 °C. The test substance has a vapour pressure of 0.42 Pa at 20 °C.

 

Absorption

Generally, oral absorption is favoured for molecular weights below 500 g/mol. The good water solubility of 1737 mg/L enables the substance to readily dissolve in the gastrointestinal fluids. In combination withthe low molecular weight of less than 200g/mol the molecules can pass through aqueous pores or can also be carried through the epithelial barrier by the bulk passage of water. The moderate log Pow value (between -1 and 4) is also favourable for passive diffusion. Taken together, the physiochemical properties indicate that 4’-methoxyacetophenone becomes bioavailable following the oral route. This assumption is confirmed by the results of the oral toxicity study, where mortality occurred. 

Due to the low volatility (vapour pressure <0.5 kPa) of4’-methoxyacetophenoneit is unlikely that the substance will be available as a vapour to a large extend, but if it is the case absorption via inhalation route might be possible due to the water solubility and the moderate log Pow value, enabling uptake directly across the respiratory tract epithelium by passive diffusion.  

Dermal absorption may also take place, favoured by the water solubility and the log Pow value, and also by the size of the molecule, even though the test results did not indicate this: No mortality occurred in an acute dermal toxicity study and no indications of a skin sensitising potential were revealed. The dermal permeability constant Kp was calculated to be 0.00348 cm/hr (Dermwin v.2.02). The test substance was found to be irritant to skin, indicating that dermal uptake might be facilitated by damaging the skin.

 

Distribution

As mentioned above, the physicochemical properties of 4’-methoxyacetophenone favour systemic absorption following oral, inhalative and dermal uptake. The systemic absorption and distribution within the body is also demonstrated by the decreased viability index of PND 4 and decreased body weights on PND 13 of the F1 pups in the OECD 422 study. 

Direct transport through aqueous pores is likely to be an entry route to the systemic circulation. After being absorbed into the body,4’-methoxyacetophenoneis most likely distributed into the interior part of cells due to its very slightly lipophilic properties (log Pow 1.79) and in turn the intracellular concentration may be slightly higher than extracellular concentration particularly in adipose tissues. 

The log Powof 4’-methoxyacetophenone indicates no bioaccumulation potential as it is below 3 and the most likely uptake mechanism into cells is passive diffusion, therefore the test substance is not considered to be bioaccumulative. 

 

Metabolism

The genotoxicity studies indicatedno remarkable differences in regard to genotoxicity and cytotoxicity in the presence or absence of metabolic activation systems. Thus a metabolic activation to more toxic metabolites was not indicated.

By using the OECD QSAR Toolbox, the following metabolites were determined:

The in vitro rat liver metabolic simulator of QSAR toolbox v4.2 predicted the following metabolites:

 

Table 1: predicted rat liver metabolites

Formaldehyde

 

 

1-(4-Hydroxyphenyl)ethanone

1-(4-Methoxyphenyl)ethanol

Formic acid

 

The skin metabolism simulator of QSAR toolbox v4.2 found the metabolites presented below.

 

Table 2: predicted skin metabolites

Formaldehyde

1-(4-Hydroxyphenyl)ethanone

Formic acid

 

Formaldehyde will be further oxidized into formate and eventually to carbon dioxide. 1-(4-Hydroxyphenyl)ethanone and 1-(4-Methoxyphenyl)ethanol may further undergo conjugation reactions to facilitate excretion via urine.

 

Excretion

The test substance will be excreted most likely in its metabolised form. The likely excretion pathway of 4’-methoxyacetophenone and its metabolites is via urine as substances with a molecular weight below 300 g/mol are prone to this pathway.